CN112391353B - 杂交瘤细胞及其制备方法、单克隆抗体及其应用 - Google Patents
杂交瘤细胞及其制备方法、单克隆抗体及其应用 Download PDFInfo
- Publication number
- CN112391353B CN112391353B CN202011203278.0A CN202011203278A CN112391353B CN 112391353 B CN112391353 B CN 112391353B CN 202011203278 A CN202011203278 A CN 202011203278A CN 112391353 B CN112391353 B CN 112391353B
- Authority
- CN
- China
- Prior art keywords
- glycocholic acid
- monoclonal antibody
- detection kit
- solution
- hybridoma cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/08—Hepato-biliairy disorders other than hepatitis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/08—Hepato-biliairy disorders other than hepatitis
- G01N2800/085—Liver diseases, e.g. portal hypertension, fibrosis, cirrhosis, bilirubin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
特异性物质 | 名称缩写 | 交叉反应率 |
牛黄胆酸钠 | TCS | 1.70% |
胆酸 | CA | 1.20% |
甘氨脱氧胆酸 | GDCA | 0.78% |
睾酮 | TESTO | 0.00% |
孕酮 | PROG | 0.00% |
熊去氧胆酸 | UDCA | -0.32% |
去氧胆酸 | DCA | -0.46% |
鹅去氧胆酸 | CDCA | -0.57% |
石胆酸 | LCA | -0.70% |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011203278.0A CN112391353B (zh) | 2020-11-02 | 2020-11-02 | 杂交瘤细胞及其制备方法、单克隆抗体及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011203278.0A CN112391353B (zh) | 2020-11-02 | 2020-11-02 | 杂交瘤细胞及其制备方法、单克隆抗体及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112391353A CN112391353A (zh) | 2021-02-23 |
CN112391353B true CN112391353B (zh) | 2022-05-10 |
Family
ID=74599092
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011203278.0A Active CN112391353B (zh) | 2020-11-02 | 2020-11-02 | 杂交瘤细胞及其制备方法、单克隆抗体及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112391353B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113295866A (zh) * | 2021-04-26 | 2021-08-24 | 深圳市龙华区中心医院 | Upⅱ抗原和upⅱ抗体联合在制备检测膀胱癌的产品中的应用 |
CN117089529B (zh) * | 2023-10-16 | 2024-03-15 | 深圳普门科技股份有限公司 | 杂交瘤细胞及其制备方法、单克隆抗体及试剂盒 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4107153A1 (de) * | 1991-03-06 | 1992-09-10 | Gregor Cevc | Praeparat zur wirkstoffapplikation in kleinsttroepfchenform |
CN103739703B (zh) * | 2014-02-11 | 2015-07-15 | 苏州博源医疗科技有限公司 | 甘胆酸免疫原、抗甘胆酸特异性抗体及检测试剂 |
CN108192875B (zh) * | 2018-03-20 | 2019-07-16 | 广东工业大学 | 杂交瘤细胞株及基于杂交瘤细胞株的甘胆酸单克隆抗体和检测试剂盒 |
CN110563840B (zh) * | 2019-04-07 | 2021-06-01 | 北京利德曼生化股份有限公司 | 抗甘胆酸单克隆抗体及其制备方法 |
-
2020
- 2020-11-02 CN CN202011203278.0A patent/CN112391353B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN112391353A (zh) | 2021-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Nishio et al. | Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis | |
CN112391353B (zh) | 杂交瘤细胞及其制备方法、单克隆抗体及其应用 | |
CN102422159B (zh) | 用于kl-6测定的免疫测定试剂 | |
US8399207B2 (en) | Monoclonal antibodies against osteopontin | |
CN102703388B (zh) | 抗人mCRP蛋白的单克隆抗体、杂交瘤细胞系和试剂盒 | |
CN104745534B (zh) | 一种降钙素原单克隆抗体杂交瘤2h4及单克隆抗体 | |
CN106226512B (zh) | 一种试剂盒、试剂盒的制备方法及利用该试剂盒实现的外周血甘氨胆酸的检测方法 | |
JP2002504994A (ja) | 抗アロタイプモノクローナル抗体を使用するイムノアッセイ | |
KR100238559B1 (ko) | 씨형 간염 바이러스에 대한 모노클로날 항체 | |
JP2021503014A (ja) | 牛妊娠関連グリコタンパク質1に特異的に結合する抗体及びその用途 | |
CN109507421B (zh) | 抗水牛IgG单克隆抗体细胞株及其制备方法和应用 | |
US11117974B2 (en) | Specifically purified anti-presepsin antibody | |
JPH05508770A (ja) | 膵臓エラスターゼ1特異性抗体、その獲得方法および該抗体を含有するテストキット | |
CN104066749A (zh) | 用于特异性识别人肝羧酸酯酶1的单克隆抗体、生成单克隆抗体的杂交瘤细胞株及其用途 | |
JP4071330B2 (ja) | 抗ヒトメダラシンモノクローナル抗体、その製造方法及びそれを用いる免疫学的測定方法 | |
JP3292728B2 (ja) | C型肝炎ウイルスに対するモノクローナル抗体およびその使用法 | |
WO2020077532A1 (zh) | 一种基于胎盘样硫酸软骨素a的癌症筛查和早期诊断的试剂方法 | |
WO1995025794A1 (fr) | Anticorps monoclonal anti-igf-i | |
CN117024595B (zh) | 抗人st2的单克隆抗体及其应用 | |
PL205979B1 (pl) | Sposób immunologicznego pomiaru zawartości ludzkiej medullazyny i sposób diagnozowania stwardnienia rozsianego | |
JP4254242B2 (ja) | 育毛活性評価方法及び育毛活性評価キット | |
ES2293924T3 (es) | Anticuerpo monoclonal antiuracilo. | |
JP4037933B2 (ja) | 抗ヒトカルシトニンモノクローナル抗体 | |
CN113583123B (zh) | 一种血浆中肝素含量的检测方法 | |
JPH06153979A (ja) | 魚類イリドウイルスに対するモノクローナル抗体並びに該抗体を製造するためのハイブリドーマ及び方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Liu Xiancheng Inventor after: Zeng Ying Inventor after: Xu Liang Inventor after: Yu Lei Inventor after: Cheng Ni Inventor after: Zhang Qingqing Inventor after: Ming Peng Inventor before: Liu Xiancheng Inventor before: Zeng Ying Inventor before: Yu Lei Inventor before: Cheng Ni Inventor before: Zhang Qingqing Inventor before: Ming Peng Inventor before: Xu Liang |
|
GR01 | Patent grant | ||
GR01 | Patent grant |